GenMark Diagnostics, Inc., a supplier of self-regulating, multiplex diagnostic tools for molecular systems, proclaimed that their company’s ‘eSensor Warfarin Sensitivity Test’ has been chosen for an important clinical Warfarin test called the WARFARIN Trial (Warfarin Adverse event Reduction for Adults Receiving genetic testing at therapy INitiation).
Boston College scientists could identify that a clump of carbon nanotubes layered with protein-targeting molecules can act as biosensors by tracking even less quantities of proteins employing the electrochemical signaling phenomenon.
Georgia Institute of Tech’s team of biomedical scientists, and microelectronics engineers, has pioneered a new Biosensing technology that could supersede the traditional microplates used in biomedical diagnostic and research laboratories.
Scientists at the Yale-based Becton Engineering and Applied Science Center, under the guidance of Professor Mark Reed, have been advancing and experimenting on biosensors which have the capability to detect cancer causing molecules in blood.
Jose Mir, President of SensiVida Medical Technologies proclaimed that, their company which manufactures painless bio-medical diagnostic equipments, has been granted the JumpStart project funding from the Cornell Center for Materials Research (CCMR) for the last quarter of 2010.
An Australia-based medical diagnostics firm, Universal Biosensor’s CEO, Mark Morrisson’s retirement has stimulated presumption in the entire industry that the company may be on sale.
Earlier this year, the North Review of Drink and Drug Driving Law highlighted the value of a spit test to catch drug drivers. Testing for drugs in saliva is very challenging, but findings announced today by Universal Sensors Ltd (Cambridge, UK) show that its Vantix biosensor technology can detect trace quantities of both cocaine and cannabis in saliva within minutes.
The NHS will be testing on the pills integrated with microchips that can inform the patients of the actual time to have the tablets, by a text message.
ForteBio, a global provider of label-free systems which enhances the production of pharmaceutical and biotherapeutic products, declared the release of its innovative Dip and Read G-Protein biosensor for fast identification and calibration of various sets of immunoglobulin (IgG), which is an antibody molecule, present in mammals.
According to guest correspondents Robert Day Lynux Works’ Vice President, and George Brooks Director of business development medical segment, virtual machinery that functions with an inherent hypervisor, detaches the medical subsystem applications from the external world.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.